Search Results - "Lecoffre, C"

NATIONAL PREVALENCE OF HYPERTENSION, TREATMENT AND CONTROL, IN FRANCE IN 2015 AND TEMPORAL TRENDS SINCE 2006 by Perrine, A.L, Lecoffre, C, Blacher, J, Olié, V

“…OBJECTIVE:The aims of this public-funded study were to assess prevalence, diagnosis, treatment and control of hypertension in the adult population in France in…”
Get full text

Regional disparities in acute and post-acute care of stroke patients in France, 2015 by de Peretti, C., Gabet, A., Lecoffre, C., Oberlin, P., Olié, Valérie, Woimant, F.

“…The aim of this study was to assess regional variations of the hospital management of stroke patients during acute and post-acute phases in France in 2015…”
Get full text

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin by Berry, C N, Girardot, C, Lecoffre, C, Lunven, C

“…The inhibitory effects of argatroban on clot- or fibrin-bound human thrombin were studied using the thrombin-specific chromogenic substrate S2238 (200 microM)…”
Get more information

Comparison Between a Self-Administered and Supervised Version of a Web-Based Cognitive Test Battery: Results From the NutriNet-Santé Cohort Study by Assmann, Karen E, Bailet, Marion, Lecoffre, Amandine C, Galan, Pilar, Hercberg, Serge, Amieva, Hélène, Kesse-Guyot, Emmanuelle

“…Dementia is a major public health problem, and repeated cognitive data from large epidemiological studies could help to develop efficient measures of early…”
Get full text

NATIONAL PREVALENCE OF HYPERCHOLESTEROLEMIA, TREATMENT AND CONTROL, IN FRANCE IN 2015 AND TEMPORAL TRENDS SINCE 2006 by Lecoffre, C., Perrine, A.L., Blacher, J., Olié, V.

Get full text

National prevalence of hypertension, treatment and control, in France in 2015 and temporal trends since 2006 by Olié, V., Perrine, A.L., Lecoffre, C., Blacher, J.

Get full text

Prevalence of cardiovascular risk factors in French adults in 2015 and time trends since 2006 by Olié, V., Perrine, A.L., Lecoffre, C., Blacher, J., Deschamps, V.

Get full text

Trends in access to stroke units and early case fatality in France – 2009-2014 by Istvan, M, Lecoffre, C, Bayat, S, Olié, V, De Peretti, C, Béjot, Y, Grimaud, O

“…Background - Stroke units (SU) improve survival and decrease disability. Issued in 2010 the French national stroke plan recommended increasing access to SU and…”
Get full text

Childhood Lead Poisoning Screening Activity in France Between 1995 and 2002 by Canoui-Poitrine, F, Harry, P, Poisot, D, Mathieu-Nolf, M, Cezard, C, Sabouraud, S, Arditti, J, Manel, J, Garnier, R, Guilbert, O, Lecoffre, C, Bretin, P

Get full text

Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time by Berry, Christopher N., Girard, Denise, Lochot, Sylvette, Lecoffre, Catherine

“…1 The antithrombotic action of argatroban, a synthetic thrombin inhibitor, was studied in three models of thrombosis in the rat, and in the tail transection…”
Get full text

SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity by Berry, Christopher N, Lassalle, Gilbert, Lunven, Catherine, Altenburger, Jean-Michel, Guilbert, Frédérique, Lalé, Alain, Hérault, Jean-Pascal, Lecoffre, Catherine, Pfersdorff, Christian, Herbert, Jean-Marc, O'Connor, Stephen E

“…SSR182289A competitively inhibits human thrombin (K(i) = 0.031 +/- 0.002 microM) and shows good selectivity with respect to other human proteases, e.g.,…”
Get more information

Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis by Berry, C N, Visconte, C, Lecoffre, C, Lochot, S, Girard, D

“…We studied the antithrombotic activity of a mixed micellar formulation containing 14 mg/ml argatroban administered by the subcutaneous (s.c.) route in rat and…”
Get more information

Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin by Lunven, C, Gauffeny, C, Lecoffre, C, O'Brien, D P, Roome, N O, Berry, C N

“…Clot-associated thrombin retains amidolytic activity, and is resistant to inhibition by heparin, but not to low molecular weight thrombin inhibitors. We show…”
Get more information

Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animals by Berry, C N, Lunven, C, Lecoffre, C, Lainée, P, O'Connor, S E, André, F, Roger, B, Garrigou-Gadenne, D, Rouchouse, A, Roome, N O, Vivan, N

“…We have studied the anticoagulant properties of a novel mixed micellar formulation containing 14 mg/ml argatroban administered by the sub-cutaneous (s.c.)…”
Get more information

Pulmonary emphysema induced by elastase: influence of the dose and effect of added collagenase by Reichart, E, Huyen, V N, Boerkmann, P, Molon-Noblot, S, Lecoffre, C

“…The endotracheal deposition of pancreatic porcine elastase (EPP) at 40 u X kg-1 body weight provokes a typical pulmonary emphysema (alveoli disruption) in…”
Get more information